Jackson Creek Investment Advisors LLC Alkermes Plc. Transaction History

Jackson Creek Investment Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	SELL	$27.17 - $31.97 $489 - $575	-18 Reduced 0.05%	34,845 $976,000
Q2 2023 Aug 02, 2023	BUY	$28.34 - $33.63 $79,153 - $93,928	2,793 Added 8.71%	34,863 $1.09 Million
Q1 2023 May 02, 2023	SELL	$25.31 - $29.02 $202 - $232	-8 Reduced 0.02%	32,070 $904,000
Q4 2022 Feb 03, 2023	SELL	$21.94 - $26.24 $26,086 - $31,199	-1,189 Reduced 3.57%	32,078 $838,000
Q3 2022 Nov 09, 2022	SELL	$22.0 - $31.87 $37,488 - $54,306	-1,704 Reduced 4.87%	33,267 $743,000
Q2 2022 Aug 04, 2022	BUY	$26.4 - $30.54 $923,234 - $1.07 Million	34,971 New	34,971 $895,000
Q4 2021 Feb 01, 2022	SELL	$21.47 - $32.08 $903,350 - $1.35 Million	-42,075 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$23.37 - $32.13 $983,292 - $1.35 Million	42,075 New	42,075 $1.3 Million

361

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.55B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.